QuantumSi Inc
$ 0.79
-2.98%
10 Aug - close price
- Market Cap 177,344,000 USD
- Current Price $ 0.79
- High / Low $ 0.84 / 0.79
- Stock P/E N/A
- Book Value 0.92
- EPS -0.50
- Next Earning Report 2026-08-13
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.25 %
- ROE -0.46 %
- 52 Week High 3.10
- 52 Week Low 0.69
About
Quantum-Si incorporated operates the first next-generation protein sequencing platform for the healthcare industries.
Analyst Target Price
$2.50
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-03-03 | 2025-11-05 | 2025-08-05 | 2025-05-15 | 2025-03-03 | 2024-11-12 | 2024-08-07 | 2024-05-09 | 2024-02-29 | 2023-11-09 | 2023-08-07 |
| Reported EPS | -0.09 | -0.0762 | -0.17 | -0.11 | -0.11 | -0.1636 | -0.16 | -0.15 | -0.12 | -0.16 | -0.15 | -0.15 |
| Estimated EPS | -0.1 | -0.1233 | -0.17 | -0.13 | -0.17 | -0.19 | -0.18 | -0.16 | -0.17 | -0.18 | -0.18 | -0.17 |
| Surprise | 0.01 | 0.0471 | 0 | 0.02 | 0.06 | 0.0264 | 0.02 | 0.01 | 0.05 | 0.02 | 0.03 | 0.02 |
| Surprise Percentage | 10% | 38.1995% | 0% | 15.3846% | 35.2941% | 13.8947% | 11.1111% | 6.25% | 29.4118% | 11.1111% | 16.6667% | 11.7647% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-13 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.13 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: QSI
2026-07-24 21:41:40
Quantum-Si Incorporated (NASDAQ: QSI) has received a notice from Nasdaq stating that its Class A common stock no longer meets the minimum $1.00 bid price requirement, having traded below this level for 30 consecutive business days. The company has an initial 180-calendar-day period, until January 19, 2027, to regain compliance by having its stock close at or above $1.00 for at least 10 consecutive business days. Failure to comply could lead to potential delisting, though options like transferring to The Nasdaq Capital Market or implementing a reverse stock split are available.
2026-07-24 19:11:09
Branford-based biotech firm Quantum-Si is once again at risk of being delisted from Nasdaq after its stock fell below the minimum $1 per share requirement for 30 consecutive business days. This marks the second time in less than two years the company has received such a warning. Quantum-Si, which commercializes protein-sequencing technology, has until January 19, 2027, to regain compliance.
2026-07-03 00:40:44
Insiders at Quantum-Si Incorporated sold US$614k worth of stock over the past year, primarily at a higher price than the current market value, suggesting they may have avoided further losses. Despite some insider buying earlier, recent insider selling of US$314k in the last three months, with no corresponding purchases, indicates potential concerns about the stock's valuation. While insiders still own 17% of the company, this selling activity warrants caution for potential investors.
2026-06-27 08:09:43
Quantum-Si (QSI) CEO Jeffrey Hawkins sold $20,996 worth of company stock across two transactions in late June to cover taxes related to vesting restricted stock units. Despite the sale, which occurred at prices between $0.88 and $1.005, Hawkins still directly holds over 3.6 million shares. The stock has seen a 59% decline over the past year, though InvestingPro analysis suggests it may be undervalued.
2026-06-26 06:39:18
This article provides an overview of Quantum-Si Incorporated (NASDAQ: QSI) stock performance, financial actuals, and analyst estimates. It covers stock price movements, historical highs and lows, market capitalization, earnings reports, and future forecasts, along with general company information like dividends and employee numbers.
2026-06-26 04:10:17
Jeffrey Alan Hawkins, CEO of Quantum-Si Inc. (NASDAQ:QSI), sold $20,996 worth of company stock in late June across two transactions. These sales were made to cover taxes related to the vesting of restricted stock units. Despite an overall stock decline, Quantum-Si reported strong Q1 2026 earnings, exceeding revenue and EPS forecasts, and is focusing on expanding its Proteus platform through new partnerships and roadshows.
